<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Pediatric Postmarketing Pharmacovigilance and Drug Utilization Reviews; Establishment of a Public Docket; Request for Comments</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Pediatric Postmarketing Pharmacovigilance and Drug Utilization Reviews; Establishment of a Public Docket; Request for Comments</h1>
    <p class="timestamp">Published: 2017-02-21 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is establishing a public docket to collect comments related to the pediatric postmarketing pharmacovigilance and drug utilization reviews of products posted between September 17, 2016, and February 24, 2017, on the FDA Web site, but will not be presented at the March 6-7, 2017, Pediatric Advisory Committee (PAC) meeting. These reviews are intended to be available for review and comment by members of the PAC, interested parties (such as academic re...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2017-03365</p>
    <p><strong>Publication Date:</strong> 2017-02-21</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2017/02/21/2017-03365/pediatric-postmarketing-pharmacovigilance-and-drug-utilization-reviews-establishment-of-a-public">https://www.federalregister.gov/documents/2017/02/21/2017-03365/pediatric-postmarketing-pharmacovigilance-and-drug-utilization-reviews-establishment-of-a-public</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2017-03365</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
